In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus
Authors
Keywords
Methicillin-resistant Staphylococcus aureus, Antimicrobial resistance, Antibiotics, Staphylococcus aureus, Antibiotic resistance, Antimicrobials, Vancomycin, Cell walls
Journal
PLoS One
Volume 13, Issue 1, Pages e0191522
Publisher
Public Library of Science (PLoS)
Online
2018-01-18
DOI
10.1371/journal.pone.0191522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
- (2017) Vidya P. Narayanaswamy et al. PLoS One
- Antimicrobial peptide exposure selects forStaphylococcus aureusresistance to human defence peptides
- (2016) Jessica Z. Kubicek-Sutherland et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
- (2016) Shankar Thangamani et al. Scientific Reports
- Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus
- (2016) Mohamed F. Mohamed et al. Scientific Reports
- Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
- (2015) Claudia Stein et al. PLoS One
- A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline
- (2014) F. K. Yam et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia
- (2014) K. E. Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline
- (2014) Rupali Jain et al. PHARMACOTHERAPY
- Progress on the development of rapid methods for antimicrobial susceptibility testing
- (2013) M. R. Pulido et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline - a cause for neutropenia
- (2013) R. H. Rimawi et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus
- (2012) Christine Seah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
- (2012) T. T. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Chitosan dressing promotes healing in third degree burns in mice: Gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling
- (2012) Ruth M. Baxter et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- (2012) Gerd Döring et al. Journal of Cystic Fibrosis
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity
- (2011) Raymond M. Dawson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibacterial action of a novel functionalized chitosan-arginine against Gram-negative bacteria
- (2010) Hong Tang et al. Acta Biomaterialia
- Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-ResistantStaphylococcus aureusIsolates during a 55-Passage Study
- (2010) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
- (2010) M. Z. David et al. CLINICAL MICROBIOLOGY REVIEWS
- Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
- (2010) Anand Kumar et al. CRITICAL CARE MEDICINE
- Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis
- (2010) Elliott C. Dasenbrook JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
- (2009) S. Svetitsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
- (2009) J. Meletiadis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
- (2009) Frank R. DeLeo et al. JOURNAL OF CLINICAL INVESTIGATION
- A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005
- (2008) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More